English
Dr. Lal PathLabs Q4 Results
- BSE: 539524
- NSE: LALPATHLAB
- ISIN: INE600L01024
- Sector: Healthcare Facilities
BSE
3,055.10
-35.65 (-1.15%)
-35.65 (-1.15%)Volume4.02 K
Updated: Tue 11 Nov, 2025 | 15:29:00
NSE
3,064.10-25.30 (-0.82%)
-25.30 (-0.82%)Volume76.73 K
Updated: Tue 11 Nov, 2025 | 15:31:14
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Dr. Lal PathLabs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 469.92 | 478.20 | -1.73% | 437.40 | 7.44% |
| Depreciation/ Amortization | 36.42 | 35.50 | 2.60% | 36.60 | -0.48% |
| Operating Income | 132.67 | 118.50 | 11.96% | 108.05 | 22.80% |
| Net Income | 154.84 | 96.70 | 60.12% | 84.54 | 83.16% |
| Other Operating Expenses Total | 122.82 | 112.60 | 9.07% | 110.80 | 10.84% |
| Net Income Before Taxes | 153.50 | 138.30 | 10.99% | 119.85 | 28.07% |
| Total Revenue | 602.60 | 596.70 | 0.99% | 545.44 | 10.48% |
| Selling/ General/ Admin Expenses Total | 192.92 | 213.10 | -9.47% | 181.08 | 6.54% |
| Diluted Normalized EPS | 18.57 | 11.58 | 60.35% | 10.17 | 82.66% |